Key Takeaways
- In 2021, 1.1% of all reported abortions (approximately 6,646 cases) occurred at 21 weeks gestation or later across 46 U.S. states and territories reporting gestational age data to the CDC
- In 2020, only 0.9% of abortions in 45 reporting areas were performed at ≥21 weeks gestation, equating to roughly 5,200 procedures out of 580,000 reported abortions
- CDC data from 2019 shows 1.3% of abortions (about 7,800) at ≥21 weeks in 38 areas with detailed gestational data
- Among adolescents aged 15-19 years reporting to CDC in 2021, 0.8% of their abortions were at ≥21 weeks (approx. 250 cases)
- In 2020 CDC data, Black women accounted for 38.4% of all late-term abortions (≥21 weeks), despite comprising 13.4% of reporters
- Hispanic women had 1.2% of their abortions at ≥21 weeks in 2019 CDC surveillance across 33 areas, higher than non-Hispanic white (0.9%)
- A 2018 study found 67% of late-term abortions (≥22 weeks) were due to fetal anomalies detected late, per medical record review of 272 cases
- Guttmacher 2014 data: 32% of abortions at 16+ weeks cited maternal health issues, rising to 50% at ≥24 weeks
- In a 2020 review of 1,000 late-term cases, 75% involved lethal fetal anomalies like anencephaly or chromosomal trisomies
- In 2021 CDC data, late-term abortions had a complication rate of 11.7% vs. 2.1% early, including hemorrhage in 4.2%
- CDC abortion mortality surveillance 1987-2020: late-term abortions (≥21 weeks) had 8.4 deaths per 100,000 vs. 0.6 overall
- 2019 study: preterm birth risk post-D&E late-term was 3.7% with cervical laceration in 2.1%
- As of 2023, 14 U.S. states have total bans on abortion with no late-term exceptions post-Dobbs, affecting 22% of women
- New York law allows abortions after 24 weeks if maternal life/health endangered, leading to 2,000+ annual late-terms
- Post-2013 Texas HB2 law, late-term abortions dropped 35% from 1,200 to 629 annually
Late-term abortions are rare medical procedures often due to serious fetal or maternal health complications.
Demographic Profiles
Demographic Profiles Interpretation
Legal, Policy, and Access Issues
Legal, Policy, and Access Issues Interpretation
Maternal and Fetal Health Risks
Maternal and Fetal Health Risks Interpretation
Medical and Fetal Indications
Medical and Fetal Indications Interpretation
Prevalence and Incidence Rates
Prevalence and Incidence Rates Interpretation
Sources & References
- Reference 1CDCcdc.govVisit source
- Reference 2GUTTMACHERguttmacher.orgVisit source
- Reference 3DSHSdshs.texas.govVisit source
- Reference 4HEALTHhealth.ny.govVisit source
- Reference 5FLORIDAHEALTHfloridahealth.govVisit source
- Reference 6CDPHcdph.ca.govVisit source
- Reference 7GOVgov.ukVisit source
- Reference 8PUBMEDpubmed.ncbi.nlm.nih.govVisit source
- Reference 9LOZIERINSTITUTElozierinstitute.orgVisit source
- Reference 10NEJMnejm.orgVisit source
- Reference 11KFFkff.orgVisit source
- Reference 12SUPREMECOURTsupremecourt.govVisit source
- Reference 13LEGINFOleginfo.legislature.ca.govVisit source
- Reference 14AZDHSazdhs.govVisit source
- Reference 15ODHodh.ohio.govVisit source
- Reference 16AIHWaihw.gov.auVisit source
- Reference 17CIHIcihi.caVisit source
- Reference 18HEALTHhealth.milVisit source
- Reference 19DPHdph.illinois.govVisit source
- Reference 20ECec.europa.euVisit source
- Reference 21MICHIGANmichigan.govVisit source
- Reference 22INin.govVisit source
- Reference 23CBScbs.nlVisit source
- Reference 24LAWlaw.lis.virginia.govVisit source
- Reference 25FDAfda.govVisit source






